These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 18511454)

  • 1. ATP-binding on fibroblast growth factor 2 partially overlaps with the heparin-binding domain.
    Rose K; Pallast S; Klumpp S; Krieglstein J
    J Biochem; 2008 Sep; 144(3):343-7. PubMed ID: 18511454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of clodronate with fibroblast growth factor 2 reduces FGF2-activity in endothelial cells.
    Rose K; Finger IE; Ferenz KB
    Biomed Pharmacother; 2011 Feb; 65(1):46-51. PubMed ID: 21177067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of amino acid residues essential for heparin binding by the A1 domain of human von Willebrand factor.
    Adachi T; Matsushita T; Dong Z; Katsumi A; Nakayama T; Kojima T; Saito H; Sadler JE; Naoe T
    Biochem Biophys Res Commun; 2006 Jan; 339(4):1178-83. PubMed ID: 16338223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laminin alpha5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparan sulfate chains of CD44.
    Hibino S; Shibuya M; Hoffman MP; Engbring JA; Hossain R; Mochizuki M; Kudoh S; Nomizu M; Kleinman HK
    Cancer Res; 2005 Nov; 65(22):10494-501. PubMed ID: 16288042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basic fibroblast growth factor: lysine 134 is essential for its neuroprotective activity.
    Rose K; Kriha D; Pallast S; Junker V; Klumpp S; Krieglstein J
    Neurochem Int; 2007 Jul; 51(1):25-31. PubMed ID: 17524524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of basic fibroblast growth factor using heparin-conjugated fibrin for therapeutic angiogenesis.
    Yang HS; Bhang SH; Hwang JW; Kim DI; Kim BS
    Tissue Eng Part A; 2010 Jun; 16(6):2113-9. PubMed ID: 20136400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of ATP with fibroblast growth factor 2: biochemical characterization and consequence for growth factor stability.
    Rose K
    BMC Biochem; 2011 Mar; 12():14. PubMed ID: 21447157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of the ligand binding domain of the fibroblast growth factor receptor: role of heparin in the activation of the receptor.
    Hung KW; Kumar TK; Kathir KM; Xu P; Ni F; Ji HH; Chen MC; Yang CC; Lin FP; Chiu IM; Yu C
    Biochemistry; 2005 Dec; 44(48):15787-98. PubMed ID: 16313182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor 2 requires complex formation with ATP for neuroprotective activity.
    Rose K; Litterscheid S; Klumpp S; Krieglstein J
    Neuroscience; 2009 Dec; 164(4):1695-700. PubMed ID: 19782732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP-dependent stabilization and protection of fibroblast growth factor 2.
    Rose K; Gast RE; Seeger A; Krieglstein J; Klumpp S
    J Biotechnol; 2010 Jan; 145(1):54-9. PubMed ID: 19836424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A structural and dynamic model for the interaction of interleukin-8 and glycosaminoglycans: support from isothermal fluorescence titrations.
    Krieger E; Geretti E; Brandner B; Goger B; Wells TN; Kungl AJ
    Proteins; 2004 Mar; 54(4):768-75. PubMed ID: 14997572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin regeneration with fibroblast growth factor 2 released from heparin-conjugated fibrin.
    Bhang SH; Sun AY; Yang HS; Rhim T; Kim DI; Kim BS
    Biotechnol Lett; 2011 Apr; 33(4):845-51. PubMed ID: 21140191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residue G346 in transmembrane segment six is involved in inter-domain communication in P-glycoprotein.
    Storm J; O'Mara ML; Crowley EH; Peall J; Tieleman DP; Kerr ID; Callaghan R
    Biochemistry; 2007 Sep; 46(35):9899-910. PubMed ID: 17696319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An intrinsic quality-control mechanism ensures unconventional secretion of fibroblast growth factor 2 in a folded conformation.
    Torrado LC; Temmerman K; Müller HM; Mayer MP; Seelenmeyer C; Backhaus R; Nickel W
    J Cell Sci; 2009 Sep; 122(Pt 18):3322-9. PubMed ID: 19706682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of molecular dynamics simulations for understanding site-directed mutagenesis of glycine residues in biotin carboxylase.
    Bordelon T; Nilsson Lill SO; Waldrop GL
    Proteins; 2009 Mar; 74(4):808-19. PubMed ID: 18704941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography.
    Platonova N; Miquel G; Chiu LY; Taouji S; Moroni E; Colombo G; Chevet E; Sue SC; Bikfalvi A
    PLoS One; 2014; 9(10):e110055. PubMed ID: 25299071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 2-induced cytoplasmic asparaginyl-tRNA synthetase promotes survival of osteoblasts by regulating anti-apoptotic PI3K/Akt signaling.
    Park SJ; Kim SH; Choi HS; Rhee Y; Lim SK
    Bone; 2009 Nov; 45(5):994-1003. PubMed ID: 19631775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor-2 binding to the endothelial basement membrane peaks at a physiologically relevant shear stress.
    Reisig K; Clyne AM
    Matrix Biol; 2010 Sep; 29(7):586-93. PubMed ID: 20678572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor 2 restrains Ras-driven proliferation of malignant cells by triggering RhoA-mediated senescence.
    Costa ET; Forti FL; Matos TG; Dermargos A; Nakano F; Salotti J; Rocha KM; Asprino PF; Yoshihara CK; Koga MM; Armelin HA
    Cancer Res; 2008 Aug; 68(15):6215-23. PubMed ID: 18676845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP acts as a regulatory effector in modulating structural transitions of cytochrome c: implications for apoptotic activity.
    Patriarca A; Eliseo T; Sinibaldi F; Piro MC; Melis R; Paci M; Cicero DO; Polticelli F; Santucci R; Fiorucci L
    Biochemistry; 2009 Apr; 48(15):3279-87. PubMed ID: 19231839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.